This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Bolanle
Olusola-Faleye

Bolanle Olusola-Faleye has over two decades of experience leading and managing diverse health programs. She specializes in strategic direction, technical leadership, and implementation of interventions to strengthen health systems, particularly in tuberculosis (TB) control and public-private partnerships. Her methodological expertise encompasses rigorous epidemiological and biostatistical approaches, health policy and management strategies, and the application of innovative programmatic and public health methodologies. Her clients have included the U.S. Agency for International Development (USAID), the Government of Nigeria, development partners, and other key stakeholders in the field of public health and TB control.

Olusola-Faleye’s current role at Abt Global is Chief of Party of the USAID Local Health System Sustainability (LHSS) project in Nigeria. She provides strategic direction and technical leadership for the implementation of integrated health system strengthening interventions to improve health service delivery, achieve better health outcomes, and move toward Universal Health Coverage. She provides technical and managerial oversight for the implementation of health financing options for families with low incomes to reduce financial barriers and out-of-pocket payments. The goal is to increase the coverage of health services to reduce health inequalities and improve access to essential health services for the most vulnerable populations.

Olusola-Faleye's extensive previous work showcases leadership roles in key public health initiatives involving TB. Before her current role, she provided technical support to the USAID Infectious Diseases Detection and Surveillance program for TB laboratory network optimization and geospatial analysis. Before that, she served as chief of party for USAID’s Sustaining Health Outcomes through the Private Sector Plus (SHOPS Plus) overseeing private sector engagement for TB service delivery in 16 states in Nigeria. Her groundbreaking work in implementing the novel Public-Private-Mix model led to remarkable improvements in TB case detection, particularly in Lagos and Kano States. As regional technical adviser, she played a crucial role in developing guidelines and protocols for managing drug resistant TB. Olusola-Faleye also contributed to global policy documents through the USAID/TB CARE International Workshop for the development of National Action Plans for Community Programmatic Management of Drug Resistant TB.

Expertise

  • Strategic direction for integrated health system strengthening programs
  • Program leadership
  • Public-private partnerships
  • Epidemiology and biostatistics
  • Tuberculosis control

Key Projects

  • TB Detection Boost in SHOPS Plus Program
  • PPM Model Implementation in 15 States and FCT
  • Private sector contributions increase in TB Notifications in Lagos and Kano
  • TB Notifications Cost-Effective Enhancement in 13 States Via PPM Light Approach
  • COVID-19 Multi-Country TB Impact Assessment with McGill University

Publications

  • Tuberculosis care quality in urban Nigeria: A cross-sectional study of adherence to screening and treatment initiation guidelines in multi-cadre networks of private health service providers. PLOS Glob Public Health 2(1): e0000150. https://doi.org/10.1371/journal.pgph.0000150
  • One year of COVID-19 and its impact on private provider engagement for TB: A Rapid Assessment of Intermediary NGOs in seven High TB burden countries. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 25 (2021) 100277
  • Impact of COVID-19 on TB active case finding in Nigeria. Public Health Action 2020, Vol 10 No 4
  • Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria. Nigeria. Afri Health Sci. 2018;18(3): 472-478. https://dx.doi.org/10.4314/ahs.v18i3.2
  • The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene 2020, 00:1-9 doi:10.1093/trstmh/trz 126
Bolanle Olusola-Faleye